Evaluation and comparison of the Minnesota Code and Novacode for electrocardiographic Q-ST wave abnormalities for the independent prediction of incident coronary heart disease and total mortality (from the Women's Health Initiative)
- PMID: 20609641
- DOI: 10.1016/j.amjcard.2010.02.007
Evaluation and comparison of the Minnesota Code and Novacode for electrocardiographic Q-ST wave abnormalities for the independent prediction of incident coronary heart disease and total mortality (from the Women's Health Initiative)
Abstract
Electrocardiographic (ECG) Q- and ST-T-wave abnormalities predict coronary heart disease (CHD) and total mortality. No comparison has been made of the classification of these abnormalities by the 2 most widely used ECG coding systems for epidemiologic studies-the Minnesota Code (MC) and Novacode (NC). We evaluated 12-lead electrocardiograms from 64,597 participants (49 to 79 years old, 82% non-Hispanic white) in the Women's Health Initiative clinical trial in 1993 to 1998, with a maximum of 11 years of follow-up. We used MC and NC criteria to identify Q-wave, ST-segment, and T-wave abnormalities for comparison. In total, 3,322 participants (5.1%) died during an average 8-year follow-up, and 1,314 had incident CHD in the baseline cardiovascular disease-free group. Independently, ECG myocardial infarction criteria by the MC or NC were generally equivalent and were strong predictors for CHD death and total mortality (hazard ratio 1.62, 95% confidence interval 1.05 to 2.51 for CHD death; hazard ratio 1.36, 95% confidence interval 1.09 to 1.71 for total mortality) in a multivariable analytic model. Electrocardiograms with major ST-T abnormalities by the MC or NC coding system were stronger in predicting CHD deaths and total mortality than was the presence of Q waves alone. In conclusion, the ECG classification systems for myocardial infarction/ischemia abnormalities from the MC and NC are valuable and useful in clinical trials and epidemiologic studies. ST-T abnormalities are stronger predictors for CHD events and total mortality than isolated Q-wave abnormalities.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Grants and funding
- N01WH22110/WH/WHI NIH HHS/United States
- N01WH24152/WH/WHI NIH HHS/United States
- N01WH32100/WH/WHI NIH HHS/United States
- N01WH32101/WH/WHI NIH HHS/United States
- N01WH32102/WH/WHI NIH HHS/United States
- N01WH32105/WH/WHI NIH HHS/United States
- N01WH32106/WH/WHI NIH HHS/United States
- N01WH32108/WH/WHI NIH HHS/United States
- N01WH32109/WH/WHI NIH HHS/United States
- N01WH32111/WH/WHI NIH HHS/United States
- N01WH32112/WH/WHI NIH HHS/United States
- N01WH32113/WH/WHI NIH HHS/United States
- N01WH32115/WH/WHI NIH HHS/United States
- N01WH32118/WH/WHI NIH HHS/United States
- N01WH32119/WH/WHI NIH HHS/United States
- N01WH32122/WH/WHI NIH HHS/United States
- N01WH42107/WH/WHI NIH HHS/United States
- N01WH42108/WH/WHI NIH HHS/United States
- N01WH42109/WH/WHI NIH HHS/United States
- N01WH42110/WH/WHI NIH HHS/United States
- N01WH42111/WH/WHI NIH HHS/United States
- N01WH42112/WH/WHI NIH HHS/United States
- N01WH42113/WH/WHI NIH HHS/United States
- N01WH42114/WH/WHI NIH HHS/United States
- N01WH42115/WH/WHI NIH HHS/United States
- N01WH42116/WH/WHI NIH HHS/United States
- N01WH42117/WH/WHI NIH HHS/United States
- N01WH42118/WH/WHI NIH HHS/United States
- N01WH42119/WH/WHI NIH HHS/United States
- N01WH42120/WH/WHI NIH HHS/United States
- N01WH42121/WH/WHI NIH HHS/United States
- N01WH42122/WH/WHI NIH HHS/United States
- N01WH42123/WH/WHI NIH HHS/United States
- N01WH42124/WH/WHI NIH HHS/United States
- N01WH42125/WH/WHI NIH HHS/United States
- N01WH42126/WH/WHI NIH HHS/United States
- N01WH42129/WH/WHI NIH HHS/United States
- N01WH42130/WH/WHI NIH HHS/United States
- N01WH42131/WH/WHI NIH HHS/United States
- N01WH42132/WH/WHI NIH HHS/United States
- N01WH44221/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
